Elad Asher
Latest contributions
TARGET-FIRST: Early aspirin discontinuation after PCI in low-risk acute MI patients
01 Sep 2025
Elad Asher provides his take on the results of TARGET-FIRST presented by Giuseppe Tarantini at the ESC Congress 2025 in Madrid.
Author
PCRonline @ ESC Congress 2025: the interventional cardiology perspective!
26 Jul 2025
Stay updated with the latest in interventional cardiology at #ESCCongress 2025!
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
PCRonline @ ACC.25 Scientific Sessions
07 Feb 2025
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25
Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism: primary outcomes from the PEERLESS randomized controlled trial
30 Oct 2024
Elad Asher provides his take on the PEERLESS trial presented by Wissam A. Jaber at TCT 2024 in Washington.
Author
PCR @ TCT 2024 - Get the international perspective!
11 Oct 2024
Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2024 - check out the list below.
ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery
31 Aug 2024
Elad Asher provides his take on the ASSURE DES trial presented by Jung-Min Ahn at the ESC Congress 2024 in London.
Author
PCRonline @ ESC Congress 2024: the interventional cardiology perspective!
26 Jul 2024
What was new and hot in interventional cardiology at #ESCCongress 2024!
One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial
07 Apr 2024
Elad Asher provides his take on the ULTIMATE-DAPT Trial results which Gregg W Stone presented at ACC.24 in Atlanta.
Author
PCRonline @ ACC.24 Scientific Sessions
22 Mar 2024
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24
PCRonline @ ESC Congress 2023: the interventional cardiology perspective!
07 Aug 2023
What was new and hot in interventional cardiology at #ESCCongress 2023!
P2Y12 inhibitor monotherapy vs DAPT after PCI with BP-EES: The SHARE Randomized Clinical Trial
26 Aug 2023
Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.
Author
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study
24 May 2023
The aim of the current trial was to explore if direct P2Y12 inhibitor monotherapy was feasible and safe in patients with NSTEMI undergoing PCI.
Reviewer
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial
22 May 2023
The EUROSHOCK trial aimed to determine if early use of VA-ECMO could improve outcomes in patients with persistent CS following pPCI.
Reviewer
ACS and SCAD
17 May 2023 – From EuroPCR 2023
Explore the captivating case of "A young farmer under pressure - when the invasive cardiologist asks for a knife," among other remarkable presentations at EuroPCR. Dig into this specific case, as well as discussions on Acute Coronary Syndrome (ACS) and Spontaneous Coronary Artery Dissection (SCAD), and...
BIOVASC: Immediate complete revascularization as safe and effective as staged procedure in treating multi-vessel disease
05 Mar 2023
Ali Nazmi Calik & Elad Asher summarize the results of the clinical trial presented by Roberto Diletti at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Author
PCRonline @ ACC.23/WCC Scientific Sessions
23 Feb 2023
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology / World Heart Federation 2023 Scientific Sessions #ACC23 #WCCardio.
Impella utilization in high-risk percutaneous coronary intervention (last remaining vessel)
01 Dec 2022
From a clean puncture to a safe utilization of Impella in high-risk PCI.
Author
Author
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
PCRonline @ TCT 2022 - Get the international perspective!
12 Sep 2022
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2022 - check out the list here!
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona
Author
PCRonline @ ESC Congress 2022: the interventional cardiology perspective!
18 Jul 2022
Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!
MIRACLE 2 score and SCAI grade to identify patients with out-of-hospital cardiac arrest for immediate coronary angiography
30 May 2022
The purpose of the current study was to evaluate the impact of performing immediate CAG post-OHCA with stratification of predicted neurologic injury and cardiogenic shock on arrival to a center.
Reviewer
Evolution and prognostic impact of cardiac damage after aortic valve replacement
24 May 2022
The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.
Reviewer
TAVI indications in complex situations
18 May 2022 – From EuroPCR 2022
Watch this session on TAVI to learn how to perform this procedure in complex situations, such as: acute myeloid leukemia and severe bicuspid aortic valve stenosis, pulmonary edema due to severe aortic stenosis, angina with complex coronary artery disease, and more!
Left main and complex bifurcation PCI in high bleeding risk patients
View the life challenging case of a 90-year-old male patient with a very active lifestyle but hypertension, dyslipidemia, ex-smoker, who presented with left main bifurcation lesion, and appreciate the value of transradial approach for left main and complex bifurcation PCI, acknowledge Ultimaster DES results in bifurcations and high...
Mitral valve-in-valve
18 May 2022 – From EuroPCR 2022
Follow LIVE this case presented by St Thomas' Hospital, London, UK, of a 73-year-old-male patient with a degenerated mitral bioprosthesis to be treated with a catheter-based approach to appreciate key steps in planning and performing transcatheter mitral ViV procedures, and discuss potential approaches to smaller valves...
TAVI in a patient with asymptomatic severe aortic stenosis - Session with LIVE case
17 May 2022 – From EuroPCR 2022
Watch this LIVE demonstration from London, United Kingdom to find out how this asymptomatic, 70-year-old, overweight, previously CABG (205) male patient with permanent atrial fibrillation and unlimited exercise tolerance was treated.
Emerging indications for TAVI
17 May 2022 – From EuroPCR 2022
NSTEMI PCI: LIVE case from St Thomas' Hospital - London, United Kingdom
17 May 2022 – From EuroPCR 2022
Watch the case of a 65-year-old ex-smoker, male patient, with hypertension and cholesterol, who presented with chest pain at rest, symptomatic with nausea and dizziness, and find out how this NSTE-ACE patient was treated.
